Specialty pharmaceutical company.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2022 | KING & SPALDING LLP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Termination |
— | |
| 2022 | KING & SPALDING LLP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| KING & SPALDING LLP | 48 | — |
| Issue | Activities |
|---|---|
| Medicare/Medicaid | 41 |
| Health Issues | 7 |